Showing results (21-30 of 118) with videos related to

Sort By:
Pageof 12
Pulmonary Pharmacology & Therapeutics|April 13, 2010
The preclinical pharmacology of roflumilast--a selective, oral phosphodiesterase 4 inhibitor in development for chronic obstructive pulmonary diseaseArmin Hatzelmann, Esteban J Morcillo, Giuseppe Lungarella, et al.
American Journal of Physiology. Lung Cellular and Molecular Physiology|January 28, 2003
Role of VEGF-B in the lung during development of chronic hypoxic pulmonary hypertensionVanessa Louzier, Bernadette Raffestin, Aude Leroux, et al.
Critical Care Medicine|March 13, 2002
Beneficial effects of nitric oxide inhalation on pulmonary bacterial clearanceDaniel Jean, Bernard Maître, Jacques Tankovic, et al.
Human Gene Therapy|June 28, 2003
Inhibition of matrix metalloproteinases by lung TIMP-1 gene transfer limits monocrotaline-induced pulmonary vascular remodeling in ratsAntoine Vieillard-Baron, Eric Frisdal, Bernadette Raffestin, et al.
Circulation Research|April 3, 2004
Serotonin-induced smooth muscle hyperplasia in various forms of human pulmonary hypertensionElisabeth Marcos, Elie Fadel, Olivier Sanchez, et al.
The Journal of Pharmacology and Experimental Therapeutics|April 24, 2009
Effects of roflumilast, a phosphodiesterase-4 inhibitor, on hypoxia- and monocrotaline-induced pulmonary hypertension in ratsMohamed Izikki, Bernadette Raffestin, Juergen Klar, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|August 15, 2009
Dichloroacetate treatment partially regresses established pulmonary hypertension in mice with SM22alpha-targeted overexpression of the serotonin transporterChristophe Guignabert, Ly Tu, Mohamed Izikki, et al.
Circulation|June 2, 2005
Serotonin transporter inhibition prevents and reverses monocrotaline-induced pulmonary hypertension in ratsChristophe Guignabert, Bernadette Raffestin, Rima Benferhat, et al.
American Journal of Respiratory Cell and Molecular Biology|April 26, 2003
Lung overexpression of angiostatin aggravates pulmonary hypertension in chronically hypoxic miceMarie-Aude Pascaud, Frank Griscelli, William Raoul, et al.
Respiratory Research|April 21, 2017
Interleukin-6 displays lung anti-inflammatory properties and exerts protective hemodynamic effects in a double-hit murine acute lung injuryGuillaume Voiriot, Keyvan Razazi, Valérie Amsellem, et al.
Pageof 12